Cargando…

Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has received global attention due to the serious threat it poses to public health. Since the outbreak in December 2019, millions of people have been affected and its rapid global spread has l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Rai C., Freitas, Humberto F., Campos, Joaquín M., Kimani, Njogu M., Silva, Carlos H. T. P., Borges, Rosivaldo S., Pita, Samuel S. R., Santos, Cleydson B. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583940/ https://www.ncbi.nlm.nih.gov/pubmed/34769170 http://dx.doi.org/10.3390/ijms222111739

Ejemplares similares

Evolutionary aspects of mutation in functional motif and post-translational modifications in SARS-CoV-2 3CLpro (Mpro): an in-silico study
por: Gupta, Amit, et al.
Publicado: (2023)

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
por: Costanzi, Elisa, et al.
Publicado: (2021)

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2
por: Bastos, Ruan S., et al.
Publicado: (2023)

A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition
por: Heilmann, Emmanuel, et al.
Publicado: (2022)

Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
por: Rizzuti, Bruno, et al.
Publicado: (2021)

Identification of Potential Antiviral Inhibitors from Hydroxychloroquine and 1,2,4,5-Tetraoxanes Analogues and Investigation of the Mechanism of Action in SARS-CoV-2
por: Ramos, Ryan S., et al.
Publicado: (2022)

Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism
por: Borges, Rosivaldo S., et al.
Publicado: (2019)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
por: Agost-Beltrán, Laura, et al.
Publicado: (2022)

Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022)

Fragment-based design of SARS-CoV-2 Mpro inhibitors
por: Teli, Divya M., et al.
Publicado: (2022)

Exploration of SARS-CoV-2 Mpro Noncovalent Natural Inhibitors Using Structure-Based Approaches
por: Duong, Cuong Quoc, et al.
Publicado: (2023)

A year in the life of SARS-CoV-2 Mpro: molecular modeling and analysis of clinically observed Mpro variants from the first year of the COVID-19 pandemic
por: Diessner, Elizabeth M., et al.
Publicado: (2022)

An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro
por: Liao, Qi, et al.
Publicado: (2021)

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
por: Papaj, Katarzyna, et al.
Publicado: (2021)

Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro
por: Tam, Nguyen Minh, et al.
Publicado: (2021)

Studies on antiviral resistant SARS-CoV-2 Mpro mutants
por: Esler, Morgan A., et al.
Publicado: (2023)

Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro
por: Yadav, Ruchi, et al.
Publicado: (2022)

Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study
por: Reyaz, Saima, et al.
Publicado: (2021)

Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions
por: Santos, Cleydson B. R., et al.
Publicado: (2023)

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2020)

Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023)

Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations
por: Zhang, Chuanming, et al.
Publicado: (2022)

Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach
por: Palanisamy, Kandhan, et al.
Publicado: (2022)

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
por: Hameedi, Mikhail Ali, et al.
Publicado: (2021)

Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
por: Hameedi, Mikhail A., et al.
Publicado: (2022)

Revisiting the Proposition of Binding Pockets and Bioactive Poses for GSK-3β Allosteric Modulators Addressed to Neurodegenerative Diseases
por: Silva, Guilherme M., et al.
Publicado: (2021)

Inhibition Kinetics and Theoretical Studies on Zanthoxylum chalybeum Engl. Dual Inhibitors of α-Glucosidase and α-Amylase
por: Kimani, Njogu M., et al.
Publicado: (2023)

SMILES-based 2D-QSAR and similarity search for identification of potential new scaffolds for development of SARS-CoV-2 MPRO inhibitors
por: Costa, Adriana Santos, et al.
Publicado: (2022)

In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
por: Cetin, Adnan
Publicado: (2021)

Potential inhibitors for SARS-CoV-2 Mpro from marine compounds
por: Tam, Nguyen Minh, et al.
Publicado: (2021)

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
por: Grottesi, Alessandro, et al.
Publicado: (2020)

Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity
por: Garland, Gavin D., et al.
Publicado: (2022)

Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study
por: Nawrot-Hadzik, Izabela, et al.
Publicado: (2021)

Machine learning combines atomistic simulations to predict SARS-CoV-2 Mpro inhibitors from natural compounds
por: Nguyen, Trung Hai, et al.
Publicado: (2023)

Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro
por: Hou, Ningke, et al.
Publicado: (2023)

Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening
por: Federico, Leonardo Bruno, et al.
Publicado: (2021)

Alkylated Sesamol Derivatives as Potent Antioxidants
por: C. Palheta, Ivanete, et al.
Publicado: (2020)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
por: Biembengut, Ísis Venturi, et al.
Publicado: (2020)

Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
por: Papaj, Katarzyna, et al.
Publicado: (2022)

De Novo design of potential inhibitors against SARS-CoV-2 Mpro
por: Li, Shimeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4mvs8n8vilgj2la6ve8qenarku